Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03366207 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)
A Phase 4 study, sponsored by Iterum Therapeutics, International Limited.
- Completed
- Registry status
- Phase 4
- Development phase
- 250
- Enrollment target
NCT03366207 is a Phase 4 study that has completed, run by Iterum Therapeutics, International Limited. The registered enrollment target is 250 participants.
The verdict
NCT03366207, a Phase 4 study, has completed, sponsored by Iterum Therapeutics, International Limited.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 250 participants
- Enrollment target
Study Summary
This is a prospective, Phase 4, open label, multi-center study of the clinical and microbiologic efficacy of ciprofloxacin for the treatment of uncomplicated urinary tract infections in adult women.
Interventions
- DRUG Ciprofloxacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2017-12-15 |
| Est. Completion | 2018-10-26 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03366207
The ClinicalTrials.gov registry entry for NCT03366207 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iterum Therapeutics, International Limited, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ciprofloxacin is the first listed.
NCT03366207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03366207 about?
NCT03366207 is a clinical study titled "Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)". This is a prospective, Phase 4, open label, multi-center study of the clinical and microbiologic efficacy of ciprofloxacin for the treatment of uncomplicated urinary tract infections in adult women.
What is the current status of trial NCT03366207?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 250 participants. The study started on 2017-12-15. Estimated completion is 2018-10-26.
What interventions are being tested in trial NCT03366207?
The interventions under investigation include: Ciprofloxacin (DRUG).
Who is sponsoring clinical trial NCT03366207?
This trial is sponsored by Iterum Therapeutics, International Limited, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.